![IJMS | Free Full-Text | Involvement of the ACE2/Ang-(1–7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19 | HTML IJMS | Free Full-Text | Involvement of the ACE2/Ang-(1–7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19 | HTML](https://www.mdpi.com/ijms/ijms-22-12955/article_deploy/html/images/ijms-22-12955-g001.png)
IJMS | Free Full-Text | Involvement of the ACE2/Ang-(1–7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19 | HTML
![PDF) Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis PDF) Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis](https://i1.rgstatic.net/publication/324505236_Pretreatment_rate_of_decay_in_forced_vital_capacity_predicts_long-term_response_to_pirfenidone_in_patients_with_idiopathic_pulmonary_fibrosis/links/5ad0e26f458515c60f4ec753/largepreview.png)
PDF) Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis
![Deborah SNIJDERS | Researcher | University of Padova, Padova | UNIPD | Department of Women's and Children's Health SDB Deborah SNIJDERS | Researcher | University of Padova, Padova | UNIPD | Department of Women's and Children's Health SDB](https://i1.rgstatic.net/ii/profile.image/279988008964102-1443765751630_Q512/Deborah-Snijders.jpg)